Tröscher et al. show that in patients with GAD65 antibody-associated temporal lobe epilepsy, cytotoxic T cells attack and kill neurons and are responsible for the early neuronal loss. bit.ly/3hglZUH

Check out our new manuscript. Many thanks for this great collaboration: @Samanth68485267, Eva Oswald, Hoi Kiu Wong, Atay Vural, Vuslat Yilmaz, Erdem Tüzün, Recai Türkoğlu, Tobias Straub, Ingrid Meinl, Franziska Thaler, Tania Kümpfel Meinl Lab,MaderLab

What happened to #neurological #autoantibody detection rates around the pandemic? We compared 2019 Vs 2020, across the 5 commonest cell surface Abs, and only saw a fall in LGI1 rates. The drop was marked around March-June - the time of the UK lockdown. jamanetwork.com/journals/jaman…

In a large cohort of patients with anti-IgLON5 disease, Grüter et al. reveal early inflammatory CSF changes, and association of HLA-DRB1*10:01 with higher autoantibody titre, consistent with a primary autoimmune nature of the disease. bit.ly/3kqYn1B

Study data support the hypothesis that the accumulation of GAD65-specific B cells and plasma cells in the CSF is an important feature of early disease stages of GAD65-Ab spectrum disorders, such as stiff-person syndrome and cerebellar ataxia. Learn more: bit.ly/3Zokjtf

Happy to share our new manuscript. Many thanks to all co-authors for this great collaboration! Katharina Eisenhut, ebelbe, MaderLab, MKerschensteiner, Meinl Lab, Neuroimmunology bit.ly/3Zokjtf

Congratulations to MaderLab on their new publication! 🥳It was a pleasure to contribute. Take a look at the pathomechanisms of MOG-antibody-associated disease: pnas.org/doi/10.1073/pn…

Thanks American Action Network Neurology Journal N2 for publishing our experience using prolonged corticosteroids for anti-LGI1 encephalitis. Examining the impact of acute immunotherapy regimen on need for maintenance immunotherapy may help optimize our treatment approach. nn.neurology.org/content/10/3/e…

Steinke et al. develop and validate a construct that neutralizes autoantibodies from patients with NMDAR encephalitis, and prevents receptor internalization and memory deficits in a mouse model. bit.ly/3Z2vgQi

Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies. New scientific commentary by Franziska Thaler & Edgar Meinl bit.ly/40NP9M6

Don’t miss this excellent updated review: “Autoimmune encephalitis: recent clinical and biological advances” ⁦@ANG_Oxford⁩ link.springer.com/article/10.100…

In NMDA receptor #encephalitis, patients with persistent CSF NMDAR-Abs at 12 months were more likely to have subsequent relapses and a poor long-term outcome

Via Neurology Journal: Researchers have found Class IV evidence of an association between rituximab and a lower hazard to relapse in patients with autoimmune encephalitis: bit.ly/3QcevkB #NeuroTwitter @AANMember